What is the Future of Nicotinic Receptor Antagonists in Cancer Therapy?
The future of nicotinic receptor antagonists in cancer therapy looks promising, especially with ongoing research and clinical trials. As we gain a better understanding of the role of nicotinic receptors in cancer, these antagonists could become an integral part of personalized cancer treatment regimens. Combining nicotinic receptor antagonists with other targeted therapies could offer a synergistic approach to effectively combat cancer.
